Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares OutstandingShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Shares Issued (2016 - 2025)

Historic Shares Issued for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $37.3 million.

  • Neurocrine Biosciences' Shares Issued rose 27300.0% to $37.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $129.4 million, marking a year-over-year increase of 597.87%. This contributed to the annual value of $129.4 million for FY2025, which is 597.87% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Shares Issued of $37.3 million as of Q4 2025, which was up 27300.0% from $45.6 million recorded in Q3 2025.
  • In the past 5 years, Neurocrine Biosciences' Shares Issued ranged from a high of $69.9 million in Q1 2024 and a low of $2.9 million during Q2 2023
  • Moreover, its 4-year median value for Shares Issued was $18.8 million (2023), whereas its average is $25.5 million.
  • The largest annual percentage gain for Neurocrine Biosciences' Shares Issued in the last 5 years was 75243.9% (2024), contrasted with its biggest fall of 7175.14% (2024).
  • Neurocrine Biosciences' Shares Issued (Quarter) stood at $15.2 million in 2021, then skyrocketed by 132.89% to $35.4 million in 2023, then tumbled by 71.75% to $10.0 million in 2024, then soared by 273.0% to $37.3 million in 2025.
  • Its Shares Issued was $37.3 million in Q4 2025, compared to $45.6 million in Q3 2025 and $14.4 million in Q2 2025.